The correlations between risk groups and previously identified immune subtypes of colon cancer indicated that there was more wound healing and fewer lymphocyte depletion, inflammatory, and IFN-γ-dominant samples in the high-risk group compared to in the low-risk group. The gene discussed is IFNG; the disease is malignant colon neoplasm.